SUMMARY The presence of circulating soluble immune complexes and the level of complement were investigated in sera from 21 patients with L3-thalassaemia major, including both splenectomised and nonsplenectomised patients. A high level of immune complexes was found in half of these cases. Reduced complement levels were seen less frequently. There was no correlation between the presence of circulating immune complexes, decreased complement levels, and the presence or absence of the spleen. The level of immune complexes increased with the age of the individual, i.e. with the duration of the disease.
Many patients with /3-thalassaemia major develop glomerulonephritis, pericarditis, or arthritis (Wasi, 1971) , and nearly all develop chronic liver disease (Masera et al., 1976) . In this last condition, circulating immune complexes are often present and they are thought to play a significant part in the genesis of these immunopathological disorders. Until now there has been no investigation of immune complexes in ,B-thalassaemia major, or of their possible association with the secondary diseases developing in thalassaemic patients. We have therefore studied a group of patients with ,B-thalassaemia major to find whether circulating immune complexes occur and, if so, whether any relation can be shown between the presence of complexes and other features of the disease.
Materials and methods
Patients. Sera from 21 patients with fi-thalassaemia major were studied. There were 13 males and 8 females, aged from 31 to 8j years. 10 had had splenectomy. All patients were treated by periodic blood transfusion. Blood samples for testing were taken immediately before transfusion. Sera from 10 healthy children of the same age range were used as controls. The blood was allowed to clot for 2 hours at room temperature and then centrifuged at 4°C. The collected serum was stored at -70°C until used.
Detection of circulating immune complexes. These were detected in native serum using radiolabelled Volanakis and Stroud (1972) . 2 mg Clq were obtained from 40 ml of serum. Purity of separated material was assessed by immunoelectrophoresis (1 % agarose) with rabbit antihuman Clq and rabbit antiwhole human serum antisera (Behringwerke, MarburgLahn). Clq was labelled with 125iodine (Radiochemical Centre, Amersham) by use of the lactoperoxidase (LP-B grade, Calbiochem, San Diego) method (Heusser et al., 1973) . The 1251-Clq with a specific activity of 1 ,uCi/,g was stored at -70°C until used.
Complement studies. Total haemolytic activity (CH50) was titrated according to Lachmann et al. (1973) The complement values of the thalassaemic patients were within the normal range, except for the values of CH50 and C3, which were, respectively, slightly reduced and slightly increased. By linear regression analysis no correlation was found between the complement levels and the values of the 125I-Clq binding activity. Discussion Our results indicate that circulating immune complexes occur in ,-thalassaemia major and that the level increases progressively with the age of the individual. Thelevel ofcirculating immune complexes did not correlate with whether or not the patient had been splenectomised, despite the fact that the mean age of the splenectomised patients was significantly higher than in the nonsplenectomised group. The presence of a considerable amount of immune complexes appears to be a common feature occurring during evolution of Cooley's anaemia. Interference with spleen function may be related to other factors including extramedullary haematopoiesis, abnormal red cell destruction, and iron overload (Pearson and O'Brien, 1975) . Immune complexes may also play an important collateral role in the splenic disorder.
Nearly all ,-thalassaemic patients develop chronic liver disease (Masera et al., 1976) . In this hepatic impairment, circulating immune complexes involving HBs antigen have been demonstrated (Theofilopoulos et al., 1976) ; in our cases HBs antigen could have been acquired as a result of repeated blood transfusion. However, other types of immune complexes could account for the high degree of 1251-Clq binding activity found in fl-thalassaemia major: anti-isoantigen antibodies, secondary to the blood transfusion therapy, have been demonstrated (Pearson and O'Brien, 1975) and isoantigen antiisoantigen complexes could be a normal feature in such cases. Immune complexes occurring in Pthalassaemia major require a characterisation to determine the nature of the antigen(s) involved.
If circulating soluble immune complexes are formed in Cooley's anaemia, they may play a role in the evolution of the disease. There is an increased incidence of infections during the disease which are often severe and lethal (Weatherall and Clegg, 1972) , although evidence of deficiency of circulating antibodies specific for the micro-organisms most frequently involved has not been shown. The presence of immune complexes may alter the immunological competence of the patients, either by a direct group.bmj.com on July 7, 2017 -Published by http://adc.bmj.com/ Downloaded from Occurrence of circulating immune complexes in P-thalassaemia major 143 blocking of the reticuloendothelial system (Mannik et al., 1974) or by consumption of complement. Immune-adherence is promoted by C3, and C5a is a potent phagocytic cell stimulator (Goldstein and Weissman, 1974) . Complement impairment may therefore involve a concomitant reduction of phagocytic efficiency. Our results may be consistent with the-hypothesis of a direct blocking of the reticuloendothelial system and did not indicate a severe impairment of complement functions, although there was some decrease in CH50 activity. Preliminary investigations (Auderset et al., 1976) suggest that a functional deficiency of properdin factor B of the alternative pathway of complement activation occurs in fi-thalassaemia major. Thus there may be two independent factors which contribute towards the diminution of immunological competence in thalassaemic patients.
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